Author

D Higbee

Observed names: D HIGBEE, D. Higbee, David Higbee, David R. Higbee

OpenAlex ID: A5005764418

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5

XXI A Brief Review of Rheumatic Fever

1946 · David Higbee · Annals of Otology Rhinology & Laryngology · 4

XVII. The Autonomic Nervous System: Some Fundamentals for Otolaryngologists

1936 · David R. Higbee · Annals of Otology Rhinology & Laryngology · 3

Peripheral cranial autonomic tracts; a study in anatomy and function.

2008 · D HIGBEE · PubMed · 2

III A New Technique for Bone Conduction Testing

1956 · David Higbee · Annals of Otology Rhinology & Laryngology · 2

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

Works count: 8

Citation count: 96

H-index: 4

I10-index: 2